News Archive

May 15, 2013 8:00am – 10:00am
Tower Club, Tysons Corner

Attracting and retaining key employees is a challenge every business faces, and government contractors know that a valuable contract can hinge on making the right staffing choices. Savvy government contractors also recognize the necessity to maximize human capital within the constraints of sequestration, continuing resolution and lowest price technically acceptable contracts.

You’re invited to this breakfast workshop to learn about powerful employee incentive compensation strategies that can provide significant competitive advantages for your business. These often underutilized plans can attract top quality employees through cash, equity and other equity-linked compensation methods. In addition to creating great work environments, innovative incentive plans allow government contractors to be successful amidst the current era of regulatory challenges.

Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR) today announced that its wholly owned subsidiary, Pluristem Ltd., has entered into an exclusive out-license agreement with United Therapeutics Corporation (Nasdaq:UTHR) for the use of Pluristem’s PLacental eXpanded (PLX) cells to develop and commercialize a cell-based product for the treatment of Pulmonary Hypertension (PH).

Under the terms of the agreement, United Therapeutics will receive exclusive worldwide licensing rights for the development and commercialization of the future product for treating PH patients. Pluristem will retain all manufacturing rights; participate in the pre-clinical and clinical trial activities, as well as provide the commercial grade product.

UK pharmaceuticals giant GlaxoSmithKline has unveiled an “open innovation” platform through which it will publish data from its clinical trials online so it can be analysed by external researchers. 

The online system allows scientists to submit a to request access anonymised drug trial data. Each request will be judged a panel of external experts appointed by GSK, and applicants must agree to publish their own findings. 

A Johns Hopkins University faculty member will be helping advise the National Institutes of Health about research topics with the most promise for addressing public health challenges.

Janice E. Clements, vice dean for faculty at the Johns Hopkins University School of Medicine, has been selected to serve on the Council of Councils for NIH. Clements was among 10 individuals newly selected to serve on the 27-member council. Her term ends in October 2015.

Venture capitalists are pushing to allow more highly educated immigrants into the U.S., saying this is essential to ensuring that the country remains an innovation leader.

One argument they use is that immigrants create jobs by starting companies. Scott Sandell, general partner at New Enterprise Associates who leads the venture firm’s technology investing, wants to support this assertion with better data.

I had the privilege to meet with and speak to the local Healthcare meet-up recently (thanks to Pete Kanee at www.healthcare.mn) and as part of my discussion, I shared a list of things that I’d encourage the local (healthcare) startups to continue to keep in mind as they grow their companies.  

These are relevant to not only healthcare-focused startups but all startups for that matter.  They’re pretty common, but in my recent conversations with healthcare entrepreneurs, I found many of these needing to be brought up as part of the dialogue.

Thursday, May 23rd at 5:00 p.m.

Join NFTE Baltimore as an honored guest at out Regional City Wide Business Plan Competition. The top size finalists will present and defend their business plans before a prestigious panel of judges and an audience of top buiness and school leaders. The networking reception will include a Student Showcase and we will also honor NFTE’s biggest supporters of youth entrepreneurship.

University of Baltimore
William T. Thumel Sr. Business Center
11 West Mount Royal Avenue

Seating is limited RSVP here by May 20th.

The University of Maryland Institute for Bioscience and Biotechnology Research (IBBR) invites you to participate in the 5th Biennial NMR Day symposium on Friday, May 17, 2013, at our facility in Rockville, Maryland.

IBBR (formerly CARB) hosts a biennial meeting, designed to promote discussion and collaboration among scientists active in the application of biomolecular NMR to modern problems in structural biology and biotechnology. The symposium speakers are internationally recognized in the application of NMR to biological systems

Emergent BioSolutions Inc. (NYSE:EBS) announced its participation in the Defence against Terrorism Programme of Work (DAT POW) workshop conducted by the North Atlantic Treaty Organization (NATO) Emerging Security Challenges Division at the Counter Terror Expo in London. An initial session of the workshop was focused on the future capabilities and protection of the Special Operations Forces (SOF) community on areas such as Improvised Explosive Devices (IEDs), Intelligence, Surveillance, Reconnaissance (ISR), Biometrics and Forensics, Information Sharing Systems, Tactical Computer, Communications, Command and Control (C4), and Force Protection.

“Emergent strongly supports NATO’s initiatives to educate on protecting those who protect the population,” said Allen Shofe, Executive Vice President of Corporate Affairs, Emergent BioSolutions. “NATO DAT POW workshops are highly relevant and informative as they cover various activities undertaken and coordinated by NATO countries.”

TOPIC: 

Leveraging USDA-ARS Partnerships and Capabilities to Help Your Business

PRESENTERS:  

Robert Griesbach, Ph.D.
Deputy Assistant Administrator Office of Technology  

James Poulos, III
Technology Transfer Coordinator  

Cathy Cohn
Technology Transfer Liaison      

Abstract:  

Agricultural Research Services (ARS) is the research arm of the Department of Agriculture that develops and transfers solutions to agricultural problems affecting Americans every day, from field to table.  To accelerate the development of new products and help move technologies into the marketplace, ARS often partners with companies and research institutions early on in the research process.  Working collaboratively alongside ARS, partners are able access and implement ARS technologies, resources and expertise to further develop specific products and create new ones.  ARS conducts research in 800 projects at 90 locations including six pilot plants and six human nutrition centers.  With a long standing commitment to technology transfer, ARS works closely with the private sector to ensure research outcomes are adopted.  Please join us to learn about the wide range of expertise and capabilities from ARS that can be used to grow your business